Trevena, Inc. (NASDAQ:TRVN) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to Trevena, Inc. First Quarter 2023 Earnings Call. All participants will be in listen only mode.
Trevena Inc (TRVN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 53,800 | $47,398 | +20% | 0% | |
| 2. | 24,400 | $21,496 | +598% | 0% | |
| 3. | Millennium Management Israel Englander | 20,750 | $18,281 | -30% | 0% |
| 4. | Renaissance Technologies Jim Simons | 182,152 | $160,000 | +159% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.79 | 56,200 | Officer, Director | 1,301,510 | 2021-06-28 | Filing | |
| $1.16 | 7,500 | Officer | 87,750 | 2019-05-31 | Filing | |
| $1.02 | 50,000 | Officer, Director | 54,000 | 2019-02-01 | Filing | |
| $1.02 | 100,000 | Director | 100,000 | 2019-02-01 | Filing | |
| $4.34 | 4,000 | Officer | 4,500 | 2016-11-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.41 | 31,785 | Officer | 873,056 | 2022-06-28 | Filing | |
| $1.76 | 5,000 | Officer | 0 | 2018-03-22 | Filing | |
| $8.00 | 23,699 | Officer | 74,761 | 2017-02-10 | Filing | |
| $10.55 | 27,217 | Officer | 1,750 | 2015-12-10 | Filing | |
| $7.00 | 44 | Officer | 31,105 | 2014-09-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 124,600 | $109,772 | 0% | |
| 2. | 112,173 | $98,824 | 0% | |
| 3. | 72,812 | $64,147 | 0% | |
| 4. | 65,167 | $57,412 | 0% | |
| 5. | 33,076 | $29,140 | 0% |
News See All
Trevena, Inc. (NASDAQ:TRVN) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Trevena Fourth Quarter and Full Year 2022 Earnings Call. As a reminder, this conference is being recorded.
Where Do Hedge Funds Stand On Trevena Inc (TRVN)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Funds Never Been Less Bullish On Trevena Inc (TRVN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Trevena Inc (TRVN) Going To Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Trevena Inc (TRVN) A Good Stock To Buy?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...
Trevena Inc (TRVN) Just Got Its Billion Dollar Pain Management Bid Underway
Trevena Inc (NASDAQ:TRVN) just kicked off a two concurrent phase III pivotals in its lead pain management candidate, Oliceridine.
Why Are These Stocks Making Headlines Today?
Although crude futures have rallied by over 2% and the Dow Jones is 100 points higher today, shares of Aduro BioTech Inc (NASDAQ:ADRO), Trevena Inc (NASDAQ:TRVN), Zynga Inc (NASDAQ:ZNGA), Charter Communications...
What Do Hedge Funds Think of Trevena Inc (TRVN)?
Insider Monkey finished processing more than 700 13F filings made by hedge funds and prominent investors. These filings show these funds' portfolio positions as of September 30.
Positive Study Results Have This Company's Shares Up By More Than 70% Today
The shares of Trevena Inc (NASDAQ:TRVN) are up by over 70% after the clinical-stage biopharmaceutical company revealed positive phase 2b study results for its postoperative pain medication last night.
Billionaire Hedge Funds
